The Peptide Pathways Report translates your results into personalized, actionable guidance
For clinician-directed use
The FDA has classified BPC-157 in Category 2 for bulk drug substances, citing possible safety issues in compounding, such as immunogenicity, impurities, and insufficient safety evidence for suggested administration routes
In the intramuscular treatment arm, vitamin B12 will be administered as follows: 1 mg on alternate days in weeks 1 and 2, 1 mg/week in weeks 38,and 1 mg/month in weeks 952
With extensive experience in supplying and trading Vitamin B12 Injection, YGIIS PHARMA has made a reputed name for itself in the market with high-quality 1 ML Diclofenac Sodium Injection IP, 10mg Ezetimibe Tablets IP, 2 ML Gentamicin Injection IP, etc